Choosing a CRO for medical devices is one of the most strategic decisions in a clinical investigation programme — and yet one of the least structured. Too often, sponsors select their partner based on price or general reputation, without assessing the specific competencies that will make the difference under the requirements of EU Regulation 2017/745 (MDR). The result: poorly designed protocols, dossiers returned by authorities, and timelines that spiral out of control. Here are the 7 criteria that truly matter.
Choosing a CRO for medical devices: why the usual criteria are no longer enough
In 2026, choosing a CRO for medical devices goes far beyond comparing price proposals. The MDR framework has fundamentally reshaped clinical requirements: the Clinical Investigation Plan (CIP) has become the central document of every submission, Post-Market Clinical Follow-up (PMCF) is now mandatory, and Article 61 of the MDR requires robust clinical evidence for any class IIb or class III device. A generalist CRO with a background in pharmaceutical trials may simply lack the device-specific regulatory maturity to navigate this environment.
Here are the 7 criteria that sponsors most frequently overlook — and that make all the difference when your dossier is assessed by the ANSM or a Notified Body.
1. Genuine mastery of ISO 14155:2026
The ISO 14155:2026 standard is the international Good Clinical Practice reference for medical device investigations. Its 2026 revision, more demanding than its predecessor, introduces the estimand framework, strengthens study governance, and more precisely structures informed consent and the role of independent committees (DMC, CEC). Always ask your CRO how it has updated its SOPs accordingly — a vague answer is a red flag.
2. The ability to connect clinical investigation, CER and PMCF
An experienced medical device CRO does not design a clinical investigation in isolation: from the outset, it maps the connection between the investigation, the Clinical Evaluation Report (CER) and the PMCF plan. This coherence is precisely what the Notified Body will assess. Before choosing a CRO for medical devices, check whether they raise the CER topic spontaneously in the first discussion — if not, they likely lack the MDR vision you need.
3. Methodological rigour over therapeutic speciality
Medical devices span enormously varied fields — cardiovascular, orthopaedics, neurosurgery, ophthalmology — but what distinguishes a strong CRO from a weak one is not primarily therapeutic speciality: it is methodological rigour. A CRO with solid MDR fundamentals — protocol design, endpoint management, ISO 14155:2026 compliance, CIP drafting — can adapt to your specific domain by drawing on expert investigators recruited for the study. Be wary of CROs whose MDR regulatory SOPs are deficient: clinical depth does not compensate for a methodological gap in front of a Notified Body.
4. Integrated device vigilance management
Device vigilance in clinical investigations is subject to strict timelines and circuits that differ from pharmacovigilance. The MDCG 2020-10/2 form, ANSM notifications and UDI traceability must be managed by specifically trained teams. When choosing a CRO for medical devices, verify that clinical vigilance is an in-house competency — not outsourced to an unsupervised third-party provider.
5. Transparency about what is subcontracted
Some CROs present a full-service offering but subcontract biostatistics, medical writing or monitoring to external providers. This is a common and acceptable practice — provided it is transparent. Request a full list of subcontractors, their MDR qualifications and the oversight arrangements. A CRO that hesitates to answer this question is not the right partner.
6. Readiness for EUDAMED
The EUDAMED Vigilance module is expected to become mandatory in 2026-2027. A CRO that has not yet registered on the platform will expose you to a real operational risk when the switch becomes compulsory. Regulatory maturity on EUDAMED is a key criterion when choosing a CRO for medical devices: ask your contact directly where their EUDAMED registration currently stands.
7. Real access to senior experts
In large CROs, the senior profiles who pitch the project often disappear after contract signature, replaced by junior staff. Confirm by name who will be responsible for your study on a day-to-day basis, their level of MDR experience and their actual availability. The AFCROS 2026 Barometer highlights that pressure on timelines and human resources is a growing challenge for industrial sponsors across Europe. A stable, senior point of contact is a decisive asset.
The checklist to go through before signing
When choosing a CRO for medical devices, ask these 5 key questions:
- Can you show me an example of a CIP you have drafted under the MDR?
- How do you integrate the CIP, CER and PMCF plan into your study approach?
- Who will be my day-to-day project lead and what is their MDR experience?
- Which subcontractors do you use and how do you supervise them?
- Are you registered on EUDAMED and have your teams been trained on the Vigilance module?
BluePharm: a CRO specialised in medical devices
Since 2017, BluePharm has supported industrial and academic sponsors in designing and conducting clinical investigations on medical devices. MDR expertise, ISO 14155:2026 mastery, integrated device vigilance management and EUDAMED support: our multidisciplinary team provides full end-to-end management of your investigation, from protocol to final report.
Are you choosing a CRO for medical devices and need a trusted partner? Contact us to discuss your project and find out how BluePharm can secure your investigation from the design phase onwards.
